MyBlueDots

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in China Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar will provide an invaluable overview of how to gain and maintain a successful pharmaceutical marketing authorisation in the People’s Republic of China (PRC), including Hong Kong, Macau and Taiwan. The two-day course offers a comprehensive overview of critical components necessary for obtaining and preserving successful marketing au

STAMFORD, Conn.–(BUSINESS WIRE)– #AI–AI-powered solutions for visual impairments, optimizing AI search and creating AI agents won ISG Startup Challenges in Paris, Dallas and London.

PLYMOUTH, Minn.–(BUSINESS WIRE)–Our proprietary technology enables precise, sustained delivery of medications, reducing dosing frequency while enhancing efficacy & patient compliance

LOS ANGELES–(BUSINESS WIRE)–WhiteHawk Capital Partners Provides Credit Facility to Nephron Pharmaceuticals

DUBLIN–(BUSINESS WIRE)–The “Telehealth and Telemedicine Market (2024 Edition): Analysis By Component (Software, Services, and Hardware), By Mode of Delivery, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)” report has been added to ResearchAndMarkets.com’s offering. The Global Telehealth and Telemedicine market showcased growth at a CAGR of 24.02% during 2020-2023. The market was valued at USD 113.28 Billion in 2023 which is expected to reach USD 462.19 Billion

BERLIN–(BUSINESS WIRE)–Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body weight which represents a gadolinium dose reduction of 60 percent compared to the macrocyclic GBCAs dosed at 0.